These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26377152)

  • 1. Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.
    Ma Y; Johnston TH; Peng S; Zuo C; Koprich JB; Fox SH; Guan Y; Eidelberg D; Brotchie JM
    Mov Disord; 2015 Aug; 30(9):1283-8. PubMed ID: 26377152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation.
    Peng S; Ma Y; Flores J; Cornfeldt M; Mitrovic B; Eidelberg D; Doudet DJ
    J Nucl Med; 2016 Oct; 57(10):1591-1598. PubMed ID: 27056614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson׳s disease-related modulation of functional connectivity associated with the striatum in the resting state in a nonhuman primate model.
    Li J; Luo C; Chen Y; Chen Q; Huang R; Sun J; Gong Q; Wu X; Qi Z; Liang Z; Li L; Li H; Li P; Wang W; Shang HF
    Brain Res; 2014 Mar; 1555():10-9. PubMed ID: 24530271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease: functional changes in frontal and parietal cortex using 18 F- fluoro-deoxy glucose positron emission tomography/computed tomography.
    Hou Z; Hong S; Sun B; Lin X; Liu Q; Yao S; Liu S
    Neurol India; 2010; 58(1):53-7. PubMed ID: 20228464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications.
    Cross DJ; Minoshima S; Nishimura S; Noda A; Tsukada H; Kuhl DE
    J Nucl Med; 2000 Nov; 41(11):1879-87. PubMed ID: 11079499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
    Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
    J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive changes of pre- and post-synaptic dopaminergic biomarkers in conscious MPTP-treated cynomolgus monkeys measured by positron emission tomography.
    Nagai Y; Obayashi S; Ando K; Inaji M; Maeda J; Okauchi T; Ito H; Suhara T
    Synapse; 2007 Oct; 61(10):809-19. PubMed ID: 17598150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
    Blesa J; Juri C; Collantes M; Peñuelas I; Prieto E; Iglesias E; Martí-Climent J; Arbizu J; Zubieta JL; Rodríguez-Oroz MC; García-García D; Richter JA; Cavada C; Obeso JA
    Neurobiol Dis; 2010 Jun; 38(3):456-63. PubMed ID: 20304066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
    Akman CI; Provenzano F; Wang D; Engelstad K; Hinton V; Yu J; Tikofsky R; Ichese M; De Vivo DC
    Epilepsy Res; 2015 Feb; 110():206-15. PubMed ID: 25616474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.
    Ma Y; Tang C; Spetsieris PG; Dhawan V; Eidelberg D
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):597-605. PubMed ID: 16804550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing.
    Moeller JR; Eidelberg D
    Brain; 1997 Dec; 120 ( Pt 12)():2197-206. PubMed ID: 9448575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in regional brain glucose metabolism measured with F-18-FDG-PET in essential tremor.
    Ha SW; Yang YS; Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2015 Apr; 56(4):482-6. PubMed ID: 24782572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.
    Brownell AL; Canales K; Chen YI; Jenkins BG; Owen C; Livni E; Yu M; Cicchetti F; Sanchez-Pernaute R; Isacson O
    Neuroimage; 2003 Oct; 20(2):1064-75. PubMed ID: 14568476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in brain FDG metabolism induced by acupuncture in healthy volunteers.
    Park MS; Sunwoo YY; Jang KS; Han YM; Kim MW; Maeng LS; Hong YP; O JH; Chung YA
    Acta Radiol; 2010 Oct; 51(8):947-52. PubMed ID: 20735279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y; Kato T; Tadokoro M; Sobue G
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic rates in small brain nuclei determined by high-resolution PET.
    Heiss WD; Habedank B; Klein JC; Herholz K; Wienhard K; Lenox M; Nutt R
    J Nucl Med; 2004 Nov; 45(11):1811-5. PubMed ID: 15534048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.